SLC48A1: A Potential Drug Target and Biomarker for Psychiatric Disorders

Target Name: SLC48A1

NCBI ID: G55652

SLC48A1

SLC48A1: A Potential Drug Target and Biomarker for Psychiatric Disorders

SLC48A1 (also known as HRG-1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SLC48 family, which is known for its role in transporting various molecules across cell membranes. One of the unique features of SLC48A1 is its ability to interact with the protein known as TrkB, which is a key regulator of neurotransmitter release.

SLC48A1 has been identified as a potential drug target for various psychiatric and neurological disorders, including depression, anxiety, and Alzheimer's disease. This is because it is involved in the transmission of neurotransmitters, which are the chemical messengers that communicate between neurons in the brain. Imbalances in neurotransmitter levels can contribute to the development and progression of these disorders.

SLC48A1 is also of interest as a biomarker for various psychiatric and neurological disorders. This is because its expression is often affected by these disorders, and may be used as a diagnostic or monitoring tool. For example, studies have shown that SLC48A1 levels are often decreased in individuals with depression and anxiety, and that they may be elevated in individuals with Alzheimer's disease. These findings suggest that SLC48A1 may be a useful biomarker for these disorders.

In addition to its potential drug and biomarker applications, SLC48A1 is also of interest as a potential therapeutic target. Its role in the regulation of neurotransmitter release suggests that it may play a key role in the development and progression of psychiatric and neurological disorders. Additionally, its unique expression pattern in various tissues makes it a promising target for small molecule inhibitors.

Overall, SLC48A1 is a protein that has significant potential as a drug target and biomarker for various psychiatric and neurological disorders. Further research is needed to fully understand its role and potential as a therapeutic target.

Protein Name: Solute Carrier Family 48 Member 1

Functions: Heme transporter that regulates intracellular heme availability through the endosomal or lysosomal compartment

The "SLC48A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC48A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets